Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07A
- Chemical subgroupJ07AJ
- Chemical substanceJ07AJ02Pertussis, purified antigen
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 1 medicine · Historical list
All medicines with Acellular pertussis vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
28 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| PentacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| AdacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| Daptacel | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| PediarixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| QuadracelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| BoostrixCombination | United States | 2.5LF, 5LF, 2.5UG, 8UG UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| BoostrixCombination | United States | 2.5LF, 5LF, 2.5UG, 8UG UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Infanrix | United States | 25LF/10LF/25UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Infanrix | United States | 25LF/10LF/25UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| KinrixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| QuadracelCombination | United States | 0.5ML | Injection | Not marketed | Sanofi Vaccines Canada Ltd. |
| Acel-P - Sus IM 300HAU | Canada | 300 UNIT / .5 ML | Suspension | Cancelled | Lederle Labs, Division of American Cyanamid Co |
| VacPertagen | European Union | Authorised | BioNet Europe | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Adacel®-Polio Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 5 µg/ 0.5 ml + 5 µg/0.5 ml + 3 µg/0.5 ml + 2.5 µg/ 0.5 ml + 2Lf + 40 D-Antigen Units + 8 D-antigen units + 32 D-antigen units + 5Lf | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Tripedia | United States | 6.7LF, 5LF, 46.8UG/.5ML | Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Tripacel VaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Boostrix VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Boostrix 0.5 ML Suspension for Injection VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Triacelluvax | European Union | Withdrawn | Chiron S.p.A. |
